• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchPropanc Biopharma
    Picture of Propanc Biopharma logo

    PPCB — Propanc Biopharma News Story

    $0.280.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    • Market Cap
      $3.03m
    • Enterprise Value
      $2.66m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • PPCB Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    PPCB Dividends
    All News

    NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM

    Picture of Propanc Biopharma logoPropanc Biopharma
    17/05/2026 08:28
    NASDAQ TRADE HALT  PPCB.O  HALT NEWS PENDING AT 03:28 AM
    

    Recent news on Propanc Biopharma

    See all news
    • NASDAQ TRADE HALT HALT NEWS PENDING AT 09:29 PM

      Yesterday 01:00
    • NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

      24/10/2026 24:50
    • Brief: Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition With Prp In Pancreatic Cancer Models, Contrasting Profile With Revolution Medicines’ Daraxonrasib

      07/10/2026 13:44
    • Brief: Propanc Biopharma Registers Resale Of 6,500,000 Shares Of Common Stock - SEC Filing

      05/10/2026 22:55
    • Brief: Propanc Biopharma To File Cta In Australia For Phase 1B Study In 30–40 Advanced Cancer Patients

      20/05/2026 13:53

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.